1. Home
  2. BHVN vs SHOO Comparison

BHVN vs SHOO Comparison

Compare BHVN & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • SHOO
  • Stock Information
  • Founded
  • BHVN 2013
  • SHOO 1990
  • Country
  • BHVN United States
  • SHOO United States
  • Employees
  • BHVN N/A
  • SHOO N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • SHOO Shoe Manufacturing
  • Sector
  • BHVN Health Care
  • SHOO Consumer Discretionary
  • Exchange
  • BHVN Nasdaq
  • SHOO Nasdaq
  • Market Cap
  • BHVN 1.9B
  • SHOO 1.4B
  • IPO Year
  • BHVN 2017
  • SHOO 1993
  • Fundamental
  • Price
  • BHVN $20.25
  • SHOO $23.85
  • Analyst Decision
  • BHVN Strong Buy
  • SHOO Hold
  • Analyst Count
  • BHVN 14
  • SHOO 7
  • Target Price
  • BHVN $62.92
  • SHOO $30.50
  • AVG Volume (30 Days)
  • BHVN 2.2M
  • SHOO 1.9M
  • Earning Date
  • BHVN 05-16-2025
  • SHOO 05-07-2025
  • Dividend Yield
  • BHVN N/A
  • SHOO 3.52%
  • EPS Growth
  • BHVN N/A
  • SHOO N/A
  • EPS
  • BHVN N/A
  • SHOO 2.32
  • Revenue
  • BHVN N/A
  • SHOO $2,284,080,000.00
  • Revenue This Year
  • BHVN N/A
  • SHOO $19.50
  • Revenue Next Year
  • BHVN $65.26
  • SHOO $8.72
  • P/E Ratio
  • BHVN N/A
  • SHOO $10.28
  • Revenue Growth
  • BHVN N/A
  • SHOO 10.34
  • 52 Week Low
  • BHVN $15.79
  • SHOO $19.05
  • 52 Week High
  • BHVN $55.70
  • SHOO $50.01
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 43.84
  • SHOO 57.26
  • Support Level
  • BHVN $18.99
  • SHOO $19.75
  • Resistance Level
  • BHVN $24.06
  • SHOO $22.02
  • Average True Range (ATR)
  • BHVN 2.03
  • SHOO 1.05
  • MACD
  • BHVN 0.24
  • SHOO 0.64
  • Stochastic Oscillator
  • BHVN 42.62
  • SHOO 92.47

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About SHOO Steven Madden Ltd.

Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.

Share on Social Networks: